Valley Brook Capital Group’s Astera Labs ALAB Stock Holding History
Bought
Maintained
Sold
Other funds holding ALAB
Valley Brook Capital Group's ALAB Position: Q3 2026 in Review
Valley Brook Capital Group increased its Astera Labs (ALAB) stake by 1.7% in Q3 2026, buying an estimated $14.5K and bringing the position to 2,645 shares worth $942K. The position accounts for 0.53% of the portfolio, ranked #47.
Valley Brook Capital Group first reported a position in ALAB in Q3 2025 and has held it in 5 quarters since. The position peaked at $1.26M in Q2 2026. 804 funds tracked by Wall St. Rank hold ALAB as of Q3 2026.
- Valley Brook Capital Group held 2,645 shares of Astera Labs worth $942K as of Q3 2026.
- Valley Brook Capital Group bought 45 Astera Labs shares in Q3 2026, an estimated $14.5K.
- Astera Labs made up 0.53% of Valley Brook Capital Group's portfolio in Q3 2026, its #47 holding.
- Valley Brook Capital Group first reported a position in Astera Labs in Q3 2025 and has held it in 5 quarters since.
- Valley Brook Capital Group's Astera Labs position peaked at $1.26M in Q2 2026.
- 804 funds tracked by Wall St. Rank held Astera Labs as of Q3 2026.
Based on Valley Brook Capital Group's 13F filing for Q3 2026, filed 26 Oct 2026.